QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,086 signal articles · 533 in last 24h · 103,714 total before filter · latest 19m ago
533last 24h
2517last 7d
483● bullish (7d)
255● bearish (7d)
197publishers
AllMacro238Earnings1486M&A143Regulatory15Product5Analyst29
✕ clear all filtersticker: AMGNsentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Jobs Numbers, SpaceX Earnings: What to Watch This Week
The Wall Street Journal2d agoneutral
Jobs Numbers, SpaceX Earnings: What to Watch This Week

The monthly jobs report comes out Friday. Before that, Elon Musk’s SpaceX will post its first earnings report as a listed company. Also reporting: Walt Disney; tech companies Palantir and Advanced Micro Devices; ride-sharing firms Uber and Lyft; private-equity firms Apollo, Carlyle and TPG; and fast-food chains McDonald's and Wendy’s.

Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel
Reuters34d agoneutral
Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel

July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's blockbuster arthritis drug Enbrel, a first-of-its-kind move ‌by a U. In granting a preliminary injunction, Chief Judge Daniel Domenico ‌of the Denver federal court said Amgen would likely face significant and irreparable harm from charging lower prices, ​adding that it could affect the drugmaker's negotiations for future contracts with wholesalers and distributors.